Advertisement
Advertisement
U.S. markets open in 4 hours 1 minute
Advertisement
Advertisement
Advertisement
Advertisement

NeuroPace, Inc. (NPCE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.12-0.24 (-4.48%)
At close: 04:00PM EDT
5.12 0.00 (0.00%)
After hours: 05:01PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close5.36
Open5.45
Bid0.00 x 1100
Ask0.00 x 800
Day's Range5.12 - 5.70
52 Week Range4.61 - 25.26
Volume35,594
Avg. Volume72,325
Market Cap125.979M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NPCE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Neuropace, Inc.
    Analyst Report: LivaNova PLCU.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management segment. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more
Advertisement
Advertisement